Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020;78(1):467-477.
doi: 10.3233/JAD-200228.

Characterizing Clinical and Neuropathological Traits of APOE Haplotypes in African Americans and Europeans

Aziz M Mezlini  1   2 , Colin Magdamo  1 , Emily Merrill  1 , Lori B Chibnik  1   2   3 , Deborah L Blacker  3   4 , Bradley T Hyman  1   2 , Sudeshna Das  1   2
Affiliations

Characterizing Clinical and Neuropathological Traits of APOE Haplotypes in African Americans and Europeans

Aziz M Mezlini et al. J Alzheimers Dis. 2020.

Abstract

Background: The APOEɛ4 allele is the largest genetic risk factor for late-onset Alzheimer's disease (AD). Recent literature suggested that the contribution of APOEɛ4 to AD risk could be population-specific, with ɛ4 conferring a lower risk to Blacks or African Americans.

Objective: To investigate the effect of APOE haplotypes on AD risk in individuals with European ancestry (EU) and Blacks or African Americans (AA).

Methods: We selected data from 1) the National Alzheimer's Coordinating Center: a total of 3,486 AD cases and 4,511 controls (N = 7,997, 60% female) with genotypes from the Alzheimer's Disease Genetics Consortium (ADGC), and 2) the Rush University Religious Orders Study and Memory and Aging Project (ROSMAP) cohort with 578 AD and 670 controls (N = 1,248, 60% female). Using ɛ3 homozygotes as the reference, we compared the association of various APOE haplotypes with the clinical and neuropathological correlates of dementia in AA and EU.

Results: In both cohorts, we find no difference in the odds or age of onset of AD among the ɛ4-linked haplotypes defined by rs769449 within either AA or EU. Additionally, while APOEɛ4 was associated with a faster rate of decline, no differences were found in rate of decline, clinical or neuropathological features among the ɛ4-linked haplotypes. Further analysis with other variants near the APOE locus failed to identify any effect modification.

Conclusion: Our study finds similar effects of the ɛ4-linked haplotypes defined by rs769449 on AD as compared to ɛ3 in both AA and EU. Future studies are required to understand the heterogeneity of APOE conferred risk of AD among various genotypes and populations.

Keywords: APOE; African Americans; Europeans; clinicopathological features; genotype.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Odds ratios of APOE haplotypes across cohorts and populations.
See this image and copyright information in PMC

References

    1. Alzheimer’s Association (2019) 2019 Alzheimer’s disease facts and figures. Alzheimers Dement 15, 321–387.
    1. Mahley RW, Rall SC Jr (2000) Apolipoprotein E: Far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1, 507–537. - PubMed
    1. Shen L, Jia J (2016) An overview of genome-wide association studies in Alzheimer’s disease. Neurosci Bull 32, 183–190. - PMC - PubMed
    1. Cuyvers E, Sleegers K (2016) Genetic variations underlying Alzheimer’s disease: Evidence from genome-wide association studies and beyond. Lancet Neurol 15, 857–868. - PubMed
    1. Lee SH, Harold D, Nyholt DR, ANZGene Consortium; International Endogene Consortium; Genetic and Environmental Risk for Alzheimer’s disease Consortium, Goddard ME, Zondervan KT, Williams J, Montgomery GW, Wray NR, Visscher PM (2013) Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer’s disease, multiple sclerosis and endometriosis. Hum Mol Genet 22, 832–841. - PMC - PubMed

Publication types

Substances

Grants and funding